FDA Inspection
Octapharma Dessau GmbHOctapharma Dessau GmbH – FDA Inspection, Nov 15, 2018
Record Details
This FDA Inspection record concerns Octapharma Dessau GmbH, with an inspection on November 15, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f82e7306-07fd-47f7-b392-df6dd70a15dd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1079455
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Octapharma Dessau GmbH
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2024 | VAI | Office of Inspections and Investigations | Blood and Blood Products |
| February 18, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Dessau GmbH
- FDA Inspection 1253986 - 2024-11-08
- FDA Inspection 960098 - 2016-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.